Stryker (NYSE:SYK) Director Ronda Stryker Sells 50,000 Shares

Key Points

• Director Ronda Stryker sold 50,000 shares at an average price of $340.10, generating $17.005 million. She retains 2,251,375 shares, worth approximately $765.7 million.
• Stryker shares fell to $327.97, while the company reported quarterly EPS of $3.69 and revenue of $6.59 billion, up 9.4% year over year. It also declared a quarterly dividend of $0.88 per share, yielding about 1.1% annually.
• Wall Street maintains a “Moderate Buy” consensus rating, with an average price target of $386.28 versus the recent share price.

Stryker Corporation (NYSE:SYK - Get Free Report) Director Ronda Stryker sold 50,000 shares of the business's stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the sale, the director directly owned 2,251,375 shares in the company, valued at approximately $765,692,637.50. The trade was a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Stryker Price Performance

Shares of NYSE:SYK traded down $12.01 during trading on Thursday, hitting $327.97. 2,232,012 shares of the company were exchanged, compared to its average volume of 2,368,609. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $396.86. The company has a market capitalization of $125.80 billion, a P/E ratio of 33.99, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The business's 50 day moving average is $326.19 and its 200-day moving average is $332.95.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping analysts' consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the previous year, the company posted $3.13 EPS. Stryker's quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities analysts forecast that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio (DPR) is 36.48%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on SYK shares. Weiss Ratings reissued a "hold (c)" rating on shares of Stryker in a report on Friday, July 31st. Wells Fargo & Company reduced their price objective on shares of Stryker from $456.00 to $418.00 and set an "overweight" rating on the stock in a research note on Friday, May 1st. Needham & Company LLC decreased their price objective on Stryker from $454.00 to $418.00 and set a "buy" rating for the company in a report on Friday, May 1st. Barclays lowered their target price on Stryker from $469.00 to $394.00 and set an "overweight" rating for the company in a research report on Monday, May 4th. Finally, Truist Financial lifted their target price on Stryker from $330.00 to $340.00 and gave the stock a "hold" rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $386.28.

Hedge Funds Weigh In On Stryker

Hedge funds have recently bought and sold shares of the company. Sankala Group LLC bought a new stake in Stryker during the fourth quarter valued at $26,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the 4th quarter valued at about $26,000. United Financial Planning Group LLC bought a new stake in shares of Stryker during the 3rd quarter valued at about $27,000. Atlas Capital Advisors Inc. bought a new stake in shares of Stryker during the 4th quarter valued at about $27,000. Finally, Gables Capital Management Inc. acquired a new stake in Stryker during the second quarter worth approximately $25,000. Institutional investors own 77.09% of the company's stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source